Opinion: Well Health to Spin Out Wellstar: Strategic SaaS Pivot or Valuation Play?
AI-generated image · Bay Street Wire
The Vancouver-based clinic network is separating its software business into a standalone TSXV listing, raising $50 million CAD to fuel AI and acquisitions.
In the world of health tech, the 'sum of the parts' argument is often the precursor to a corporate divorce. For Well Health, a Vancouver-based clinic network, that moment has arrived.
As BetaKit first reported, Well Health has announced it will spin out its pure-play software subsidiary, Wellstar, to be listed on the TSX Venture Exchange (TSXV) later this year. The maneuver involves Wellstar combining with an unnamed BC-based shell company, a deal expected to close this September provided it receives preliminary approval for the listing.
**The Strategic Split**
The move creates a clear divide between Well Health’s two primary engines. The parent company will continue to operate its network of approximately 270 medical clinics across Canada, while Wellstar will operate as a standalone entity focused on clinical software tools.
Despite the separation, the ties remain tight. Well Health stated it expects to continue as a "growing customer" and a "significant long-term controlling shareholder" of Wellstar.
**Unlocking Value or Offloading Pressure?**
From my perspective as a columnist, the central question is whether this is a genuine pivot toward a scalable SaaS model or a tactical move to alleviate valuation pressures on the parent company.
Well Health chairman and CEO Hamed Shahbazi framed the transaction as a way to "unlock the value" of the company's healthcare technology assets. In a statement, Shahbazi noted that a standalone listing provides Wellstar with increased investor visibility, better flexibility, and improved access to growth capital.
This isn't a snap decision. As BetaKit reports, Well Health has been telegraphing this move for nearly two years. During a Q2 2024 earnings call, Shahbazi explicitly mentioned that the company was undervalued relative to its individual components, suggesting that making Wellstar (which was then known as Well Provider Solutions) a public company controlled by Well Health by early 2025 would unlock that value.
**Capital and Expansion**
Well Health has spent the intervening period preparing Wellstar for independence by accumulating assets and capital. BetaKit notes that Wellstar has already raised more than $100 million through two separate equity financings. Additionally, the software arm acquired two unnamed Canadian medical billing companies earlier this year to expand its product offerings prior to the spinout.
As part of the current deal, Wellstar is raising $50 million CAD via a private placement. These subscription receipts are priced at $10 each and will be converted into shares for investors. Well Health indicated that these funds will be released to Wellstar upon the closing of the deal to support organic growth, AI-related innovation, future acquisitions, and general corporate purposes.